NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/30/2017
Back to search
Official data from USPTO
MEDA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MEDA
ST13
US500000077234664Class
5, 10, 35, 42, 44
Filing
77234664
Registration
3536003
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
49
Latest update
12/30/2017
Trademark type
Word
Nice classes
5, 10, 35, 42, 44
Filing date
07/20/2007
Registration date
11/25/2008
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/30/2017
Last transaction
12/30/2017
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
03
Owner location
Solona, SE
Examiner
FAHRENKOPF, PAUL
Law office
L10
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Meda AB
Representatives
Mylan Inc. IP Department - Trademarks Mylan
Technical classification
Nice Classes
Class 5Class 10Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical productspharmaceutical preparations for the prevention and treatment of disorders and diseases of the brain and the nervous systemthe eyesthe respiratory tractthe immune system and the skin; analgesicanti-rheumaticanti-inflammatoryanti-allergicneurological and cardiovascular medicine; pharmaceutical preparationsantidiabetics; pharmaceutical preparations for the treatment of diseases of the central nervous system; Pharmaceutical Drugs Containing Chamomile for the Treatment of Disorders of the SkinEarsGums and MouthRespiratoryGastro-Intestinal and Urogenital Systems; pharmaceutical preparationsantibiotics; pharmaceutical preparations for the treatment of infections; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for the treatment of urogenital diseases and disorders; sanitary preparations for medical use; medical plasters and wound dressings
Class 10
Medical apparatus for facilitating the inhalation of pharmaceutical preparations; Medical apparatus for introducing pharmaceutical preparations into the human body; Medical apparatus for treating respiratory conditions; Medical inhalers for therapeutic use sold empty
Class 35
Managementbusiness managementbusiness management planningbusiness management and advicebusiness management consultancy services
Class 42
Scientific research; Scientific researchconducting clinical trials; Scientific research in the field of pharmaceuticals and clinical trials; Technological servicesdesign and testing for new product development; Technological servicesdesign and testing of new products for others; Industry analysis and research servicespharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and developmentpharmaceutical research services and testing; inspection or research of pharmaceuticals
Class 44
Medical services; health care; providing information about health care
Publications
History of USPTO decisions and trademark events.
49 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12/30/2017
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/30/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/30/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/01/2017
E89R
TEAS SECTION 8 & 9 RECEIVED
12/01/2017
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
11/25/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/06/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/06/2017
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/20/2015
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/20/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/20/2015
E815
TEAS SECTION 8 & 15 RECEIVED
02/04/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
11/25/2008
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
10/21/2008
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/21/2008
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/21/2008
IUCN
NOTICE OF ALLOWANCE CANCELLED
10/20/2008
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
10/20/2008
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/15/2008
UNDC
UNDELIVERABLE MAIL - COURTESY COPY MAILED
10/10/2008
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
10/07/2008
PUBO
PUBLISHED FOR OPPOSITION
07/15/2008
NPUB
NOTICE OF PUBLICATION
06/25/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/09/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/06/2008
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
05/15/2008
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
05/12/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/30/2008
ALIE
ASSIGNED TO LIE
04/30/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/30/2008
XAEC
EXAMINER'S AMENDMENT ENTERED
04/30/2008
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/30/2008
GNEA
EXAMINERS AMENDMENT E-MAILED
04/30/2008
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/30/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/28/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/28/2008
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/28/2008
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/28/2008
GNSL
LETTER OF SUSPENSION E-MAILED
01/28/2008
CNSL
SUSPENSION LETTER WRITTEN
01/28/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/31/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/31/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/31/2007
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/02/2007
GNRT
NON-FINAL ACTION E-MAILED
11/02/2007
CNRT
NON-FINAL ACTION WRITTEN
11/02/2007
DOCK
ASSIGNED TO EXAMINER
10/25/2007
NWAP
NEW APPLICATION ENTERED
07/25/2007
Continuous trademark protection
Get notified about every new filing that threatens MEDA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.